Suven Life Sciences Balance Sheet Health
Financial Health criteria checks 6/6
Suven Life Sciences has a total shareholder equity of ₹2.7B and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹2.8B and ₹148.6M respectively.
Key information
0%
Debt to equity ratio
₹0
Debt
Interest coverage ratio | n/a |
Cash | ₹2.40b |
Equity | ₹2.70b |
Total liabilities | ₹148.62m |
Total assets | ₹2.85b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 530239's short term assets (₹2.6B) exceed its short term liabilities (₹135.2M).
Long Term Liabilities: 530239's short term assets (₹2.6B) exceed its long term liabilities (₹13.5M).
Debt to Equity History and Analysis
Debt Level: 530239 is debt free.
Reducing Debt: 530239 has no debt compared to 5 years ago when its debt to equity ratio was 1.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 530239 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 530239 has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 14.4% each year.